RegulatoryRegulatoryPHN-03062026-10-20 08:03 CT
FDA Issues Final Guidance on Prescription Drug Apps and Software
Source · FDA press releases
TLDR
The FDA released final guidance on how drug companies can develop, distribute, and label apps used alongside prescription medicines. The excerpt does not identify any peptide medicines or provide details of the guidance.
01—Key points
- 01The guidance addresses apps used alongside prescription medicines.
- 02It covers app development, distribution, and labeling by drug companies.
- 03No peptide-specific provisions are described in the excerpt.
Why it matters Editorial
The guidance establishes a framework for prescription drug apps, but the excerpt does not establish a specific connection to peptide medicines.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.